113 related articles for article (PubMed ID: 25726970)
1. Throbbing headache associated with enoxaparin administration: a case report, a review of pharmacovigilance databases for similar cases and possible mechanisms.
Brusadelli T; Carnovale C; Gentili M; Borsadoli C; Speziali A; Perrone V; Pellegrino P; Antoniazzi S; Pozzi M; Radice S; Clementi E
J Clin Pharm Ther; 2015 Jun; 40(3):342-4. PubMed ID: 25726970
[TBL] [Abstract][Full Text] [Related]
2. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin induced reactive thrombocytosis: a rare adverse drug reaction.
Meenpidiyil SS; Azeez S; Kumar VP; Suresh D; Kalathathoduuill S; Thandupara S; Puthukudi MH
J Basic Clin Physiol Pharmacol; 2020 Jun; 31(5):. PubMed ID: 32589604
[TBL] [Abstract][Full Text] [Related]
4. Delayed hypersensitivity to enoxaparin.
Cabañas R; Caballero MT; López-Serrano MC; Díaz R; Contreras J; Barranco P; Moreno-Ancillo A
J Investig Allergol Clin Immunol; 1998; 8(6):383-4. PubMed ID: 10028487
[TBL] [Abstract][Full Text] [Related]
5. [Enoxaparin-induced cutaneous necrosis localized on insulin lipodystrophies].
Lefebvre I; Delaporte E; Dejobert Y; Catteau B; Piette F; Bergoend H
Ann Dermatol Venereol; 1997; 124(5):397-400. PubMed ID: 9739898
[TBL] [Abstract][Full Text] [Related]
6. Enoxaparin use in the neonatal intensive care unit: experience over 8 years.
Malowany JI; Knoppert DC; Chan AK; Pepelassis D; Lee DS
Pharmacotherapy; 2007 Sep; 27(9):1263-71. PubMed ID: 17723080
[TBL] [Abstract][Full Text] [Related]
7. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
[TBL] [Abstract][Full Text] [Related]
8. Bullous hemorrhagic dermatosis induced by enoxaparin.
Gouveia AI; Lopes L; Soares-Almeida L; Filipe P
Cutan Ocul Toxicol; 2016; 35(2):160-2. PubMed ID: 25942690
[TBL] [Abstract][Full Text] [Related]
9. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
Klamroth R; Gottstein S; Essers E; Landgraf H
Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
[TBL] [Abstract][Full Text] [Related]
10. Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety.
Kane-Gill SL; Feng Y; Bobek MB; Bies RR; Pruchnicki MC; Dasta JF
J Clin Pharm Ther; 2005 Jun; 30(3):207-13. PubMed ID: 15896237
[TBL] [Abstract][Full Text] [Related]
11. An unusual case of massive subcutaneous chest wall haemorrhage with enoxaparin.
Rahman MS; Soo L; Qasim A
Acute Card Care; 2011 Sep; 13(3):199-201. PubMed ID: 21877880
[TBL] [Abstract][Full Text] [Related]
12. A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Weitz JI; Cao C; Eriksson BI; Fisher W; Kupfer S; Raskob G; Spaeder J; Turpie AG
Thromb Haemost; 2010 Dec; 104(6):1150-7. PubMed ID: 20886185
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
[TBL] [Abstract][Full Text] [Related]
14. Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars.
Grampp G; Bonafede M; Felix T; Li E; Malecki M; Sprafka JM
Expert Opin Drug Saf; 2015 Mar; 14(3):349-60. PubMed ID: 25557261
[TBL] [Abstract][Full Text] [Related]
15. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
Weiss A; Brose S; Ploetze K; Matschke K
Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
[TBL] [Abstract][Full Text] [Related]
16. Comparison of minor bleeding complications using dabigatran or enoxaparin after cemented total hip arthroplasty.
Gombár C; Horvath G; Gálity H; Sisák K; Tóth K
Arch Orthop Trauma Surg; 2014 Apr; 134(4):449-57. PubMed ID: 24488447
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
[TBL] [Abstract][Full Text] [Related]
18. [General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years].
Slunsky R
Zentralbl Gynakol; 1995; 117(11):598-601. PubMed ID: 8533494
[TBL] [Abstract][Full Text] [Related]
19. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Mahaffey KW; Tonev ST; Spinler SA; Levine GN; Gallo R; Ducas J; Goodman SG; Antman EM; Becker RC; Langer A; White HD; Aylward PE; Col JJ; Ferguson JJ; Califf RM;
Int J Cardiol; 2010 Mar; 139(2):123-33. PubMed ID: 19012977
[TBL] [Abstract][Full Text] [Related]
20. Recurrent life-threatening deep tissue hematomas after switching to generic enoxaparin: a report and perspective on the approval process for biological compounds.
Kaffenberger BH; Bekaii-Saab T
Clin Appl Thromb Hemost; 2012; 18(1):104-6. PubMed ID: 21873360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
